Evidence map›Paper›PMID 35055008›Full record

ArticleInternational journal of molecular sciences2022

Exosomal and Plasma Non-Coding RNA Signature Associated with Urinary Albumin Excretion in Hypertension.

Angela L Riffo-Campos, Javier Perez-Hernandez, Ana Ortega, Olga Martinez-Arroyo, Ana Flores-Chova, Josep Redon, Raquel Cortes

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Emerging role of exosomes in vascular diseases.Frontiers in cardiovascular medicine · 2023
    Review
  12. Emerging Roles of Extracellular Non-Coding RNAs in Vascular Diseases.Journal of cardiovascular translational research · 2022
    Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Angela L Riffo-CamposMillennium Nucleus on Sociomedicine (SocioMed) and Vicerrectoría Académica, Universidad de La Frontera, Temuco 4780000, Chile.ORCID 0000-0001-6300-3338
Javier Perez-HernandezCardiometabolic and Renal Risk Research Group, INCLIVA Biomedical Research Institute, 46010 Valencia, Spain.ORCID 0000-0001-9712-2917
Ana OrtegaCardiometabolic and Renal Risk Research Group, INCLIVA Biomedical Research Institute, 46010 Valencia, Spain.ORCID 0000-0002-9763-0505
Olga Martinez-ArroyoCardiometabolic and Renal Risk Research Group, INCLIVA Biomedical Research Institute, 46010 Valencia, Spain.ORCID 0000-0001-9602-8419
Ana Flores-ChovaCardiometabolic and Renal Risk Research Group, INCLIVA Biomedical Research Institute, 46010 Valencia, Spain.
Josep RedonCardiometabolic and Renal Risk Research Group, INCLIVA Biomedical Research Institute, 46010 Valencia, Spain.ORCID 0000-0001-8777-6773
Raquel CortesCardiometabolic and Renal Risk Research Group, INCLIVA Biomedical Research Institute, 46010 Valencia, Spain.ORCID 0000-0001-9607-997X
INCLIVA Health Research Institute · ESCentre National de la Recherche Scientifique · FRInstituto de Salud Carlos III · ESUniversidad de La Frontera · CL

Funding

European Regional Development FundInstituto de Salud Carlos III PI12/02615; PI18/01405; PI19/01796Instituto de Salud Carlos III Sara Borrell, CD18/00166Ministerio de Ciencia e Innvoacion PID2020-117114GB-I00
6 · The paper itself

Abstract

Non-coding RNA (ncRNA), released into circulation or packaged into exosomes, plays important roles in many biological processes in the kidney. The purpose of the present study is to identify a common ncRNA signature associated with early renal damage and its related molecular pathways. Three individual libraries (plasma and urinary exosomes, and total plasma) were prepared from each hypertensive patient (with or without albuminuria) for ncRNA sequencing analysis. Next, an RNA-based transcriptional regulatory network was constructed. The three RNA biotypes with the greatest number of differentially expressed transcripts were long-ncRNA (lncRNA), microRNA (miRNA) and piwi-interacting RNA (piRNAs). We identified a common 24 ncRNA molecular signature related to hypertension-associated urinary albumin excretion, of which lncRNAs were the most representative. In addition, the transcriptional regulatory network showed five lncRNAs (LINC02614, BAALC-AS1, FAM230B, LOC100505824 and LINC01484) and the miR-301a-3p to play a significant role in network organization and targeting critical pathways regulating filtration barrier integrity and tubule reabsorption. Our study found an ncRNA profile associated with albuminuria, independent of biofluid origin (urine or plasma, circulating or in exosomes) that identifies a handful of potential targets, which may be utilized to study mechanisms of albuminuria and cardiovascular damage.

Indexed as

Cell-Free Nucleic AcidsExosomesTranscriptomeAlbuminuriaBiomarkersBlood PressureDisease SusceptibilityFemaleGene Expression ProfilingGene Expression RegulationGene Regulatory NetworksHumansHypertensionLiquid BiopsyMaleRNA, UntranslatedBiomarkersCell-Free Nucleic AcidsRNA, Untranslatedexosomeshypertensionnon-coding RNAplasmaurinary albumin excretion

Identifiers

PMID35055008
PMCPMC8775608
OpenAlexW4206471298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.